Skip to main content

Table 3 Dosimetric parameters of OARs and delivery efficiency for whole and partial arc plans on the Trilogy and Halcyon

From: Treatment planning comparison of volumetric modulated arc therapy with the trilogy and the Halcyon for bilateral breast cancer

 

T-4arc

T-8arc

H-4arc

H-8arc

p < 0.05

Heart

     

 V5 (%)

20.4 ± 6.2

13.7 ± 4.9

30.5 ± 6.2

49.2 ± 4.5

a,b,c,d

 V10 (%)

8.5 ± 3.3

8.0 ± 3.7

10.2 ± 2.9

15.0 ± 6.4

 V20 (%)

3.4 ± 1.5

4.0 ± 2.4

2.7 ± 1.3

5.8 ± 4.0

b

 V30 (%)

1.1 ± 0.6

1.8 ± 1.7

0.8 ± 0.5

2.7 ± 2.8

b,c

 V40 (%)

0.2 ± 0.2

0.6 ± 0.9

0.1 ± 0.1

1.1 ± 1.8

b,c

 Dmean (Gy)

4.9 ± 0.6

3.9 ± 1.1

5.6 ± 0.6

7.1 ± 1.6

a,b,c,d

LV

     

 V5 (%)

34.2 ± 10.3

23.9 ± 7.6

35.7 ± 9.3

48.9 ± 14.8

a,c

 V10 (%)

17.5 ± 6.6

15.5 ± 6.6

16.1 ± 5.9

22.9 ± 9.8

 V20 (%)

7.6 ± 3.0

9.1 ± 5.2

5.8 ± 2.7

12.0 ± 7.7

b

 V30 (%)

2.7 ± 1.3

4.7 ± 4.0

1.9 ± 1.0

6.5 ± 6.2

b,c

 V40 (%)

0.5 ± 0.5

1.6 ± 2.0

0.2 ± 0.1

2.9 ± 4.1

a,b,c

 Dmean (Gy)

6.9 ± 1.3

6.0 ± 2.0

6.8 ± 1.1

9.2 ± 3.0

b

 LAD

     

 V5 (%)

85.7 ± 14.5

76.0 ± 11.4

84.6 ± 13.4

89.3 ± 8.7

 V10 (%)

61.6 ± 16.5

63.6 ± 16.9

63.2 ± 17.2

67.5 ± 16.6

 V20 (%)

43.3 ± 17.7

47.5 ± 21.8

43.1 ± 19.1

52.9 ± 21.7

 V30 (%)

24.2 ± 15.5

25.7 ± 20.5

14.3 ± 10.9

31.2 ± 18.2

b

 V40 (%)

1.2 ± 1.5

6.5 ± 15.4

0.1 ± 0.3

9.8 ± 15.9

b

 Dmax (Gy)

40.4 ± 4.2

41.9 ± 4.2

38.9 ± 3.1

42.5 ± 4.4

b

 Dmean (Gy)

18.1 ± 4.7

19.0 ± 6.3

17.2 ± 4.0

21.3 ± 5.8

b

Lungs

     

 V5 (%)

45.1 ± 3.1

30.4 ± 3.5

43.7 ± 4.1

49.1 ± 4.7

a,b,c

 V10 (%)

23.9 ± 2.6

19.4 ± 2.6

22.9 ± 2.6

25.5 ± 2.9

a,c

 V20 (%)

13.4 ± 2.2

12.4 ± 2.6

13.2 ± 2.5

15.8 ± 3.0

 V30 (%)

7.9 ± 1.8

8.5 ± 2.3

8.0 ± 2.1

10.6 ± 3.0

 V40 (%)

3.2 ± 1.1

5.0 ± 1.9

3.5 ± 1.4

6.0 ± 2.5

a,b

 Dmean (Gy)

9.1 ± 0.7

7.5 ± 1.0

9.1 ± 0.8

9.2 ± 3.0

a,c

Skin

     

 V30 (%)

67.3 ± 8.7

68.9 ± 8.2

74.2 ± 7.6

75.2 ± 6.9

c,d

 V40 (%)

31.3 ± 7.9

32.4 ± 8.5

40.4 ± 8.8

41.5 ± 7.3

c,d

 V45 (%)

7.9 ± 3.7

9.3 ± 3.7

16.8 ± 4.3

17.5 ± 3.3

c,d

 V50 (%)

0.0 ± 0.1

0.0 ± 0.0

0.3 ± 0.2

0.5 ± 0.5

c,d

 Dmean (Gy)

33.9 ± 2.0

34.3 ± 1.9

36.0 ± 1.9

36.3 ± 1.6

c,d

Liver

     

 Dmean (Gy)

5.7 ± 1.5

3.9 ± 1.1

6.0 ± 1.1

6.7 ± 1.5

a,c

 MU

1170.8 ± 97.3

1051.5 ± 70.1

1036.1 ± 103.8

831.6 ± 45.2

a,b,d

 Delivery time (min)

6.1 ± 0.6

6.0 ± 0.9

2.2 ± 0.2

2.2 ± 0.4

c,d

  1. a: T-4arc versus T-8arc, b: H-4arc versus H-8arc, c: T-8arc versus H-4arc, d: T-4arc versus H-4arc